JAC-Antimicrobial Resistance · 2020 · 74 citations · 6 references
Veterinary MedicineInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial StewardshipMedical MicrobiologyAntimicrobial TherapyBacterial InfectionsPneumonia PharmacotherapyPulmonary InfectionsRespiratory InfectionsRespiratory Tract InfectionsAntimicrobial Prescribing PatternsBacterial CoinfectionDuration In Pneumonia TreatmentDuration Of Antimicrobial TreatmentEmpirical Antimicrobial TreatmentInpatient Antimicrobial StewardshipSars-cov-2 InfectionSars-cov-2 Pneumonia
BACKGROUND: Bacterial respiratory coinfection in the setting of SARS-CoV-2 infection remains poorly described. A description of coinfection and antimicrobial usage is needed to guide ongoing antimicrobial stewardship. OBJECTIVES: To assess the rate of empirical antimicrobial treatment in COVID-19 cases, assess the rate and methods of microbiological sampling, assess the rate of bacterial respiratory coinfections and evaluate the factors associated with antimicrobial therapy in this cohort. METHODS: Inpatients with positive SARS-CoV-2 PCR were recruited. Antibiotic prescription, choice and duration were recorded. Taking of microbiological samples (sputum culture, blood culture, urinary antigens) and culture positivity rate was also recorded. Linear regression was performed to determine factors associated with prolonged antimicrobial administration. RESULTS: A total of 117 patients were recruited; 84 (72%) were prescribed antimicrobial therapy for lower respiratory tract infections. Respiratory pathogens were identified in seven (6%) patients. The median duration of antimicrobial therapy was 7 days. C-reactive protein level, oxygen requirement and positive cultures were associated with prolonged duration of therapy. CONCLUSIONS: The rate of bacterial coinfection in SARS-CoV-2 is low. Despite this, prolonged courses of antimicrobial therapy were prescribed in our cohort. We recommend active antimicrobial stewardship in COVID-19 cases to ensure appropriate antimicrobial prescribing.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Clinical Characteristics of Coronavirus Disease 2019 in China
Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
Risk-stratification methods for identifying patients for care coordination.
Lindsey R. Haas, Paul Y. Takahashi, Nilay D. Shah et al. · PubMed · 2013 · 115 citations